As a forward-thinking medical device company specializing in the development of AI-powered surgical robotic systems and innovative surgical instruments, Baird Medical is committed to delivering ...
olastrocel is an allogeneic, off-the-shelf cellular therapeutic candidate derived from perinatal tissue and developed under the Company’s AlloStem® platform. It is in clinical development for: ...
CALGARY, AB , Dec. 5, 2025 /CNW/ - Ava Industries (Ava), a Canadian health-technology company founded and built by physicians, announced the regional rollout of a new set of tools within Ava, its ...
NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) ...
Advances in technology and treatment planning have made shorter-course radiation a safe, effective and patient-centered ...
"Subsidiaries deliver strong revenue performance as MDCE advances development of innovative AI-driven health and nutrition technologies." MESA, ARIZONA / ACCESS Newswire / November 24, 2025 / Medical ...
Over 500 in-person participants from 103 countries and more than 3000 virtual participants attended the fifth International Conference on Hybrid Imaging to strengthen the practice of nuclear medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback